CN108374039B - 一种人乳头瘤病毒的快速检测方法、液相芯片及试剂盒 - Google Patents
一种人乳头瘤病毒的快速检测方法、液相芯片及试剂盒 Download PDFInfo
- Publication number
- CN108374039B CN108374039B CN201810102320.6A CN201810102320A CN108374039B CN 108374039 B CN108374039 B CN 108374039B CN 201810102320 A CN201810102320 A CN 201810102320A CN 108374039 B CN108374039 B CN 108374039B
- Authority
- CN
- China
- Prior art keywords
- hpv
- liquid phase
- group
- marker
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000701806 Human papillomavirus Species 0.000 title claims abstract description 56
- 238000001514 detection method Methods 0.000 title claims abstract description 47
- 239000007791 liquid phase Substances 0.000 title claims abstract description 23
- 239000004005 microsphere Substances 0.000 claims abstract description 70
- 239000000523 sample Substances 0.000 claims abstract description 65
- 239000003550 marker Substances 0.000 claims abstract description 57
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 39
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 31
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 31
- 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 6
- 230000000295 complement effect Effects 0.000 claims abstract description 4
- 208000022361 Human papillomavirus infectious disease Diseases 0.000 claims description 154
- 238000009396 hybridization Methods 0.000 claims description 16
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 10
- 241000341655 Human papillomavirus type 16 Species 0.000 claims description 10
- 230000008696 hypoxemic pulmonary vasoconstriction Effects 0.000 claims description 10
- 108010090804 Streptavidin Proteins 0.000 claims description 8
- 239000002773 nucleotide Substances 0.000 claims description 8
- 125000003729 nucleotide group Chemical group 0.000 claims description 8
- KZMAWJRXKGLWGS-UHFFFAOYSA-N 2-chloro-n-[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]-n-(3-methoxypropyl)acetamide Chemical compound S1C(N(C(=O)CCl)CCCOC)=NC(C=2C=CC(OC)=CC=2)=C1 KZMAWJRXKGLWGS-UHFFFAOYSA-N 0.000 claims description 7
- 241000701828 Human papillomavirus type 11 Species 0.000 claims description 7
- 229960002685 biotin Drugs 0.000 claims description 7
- 239000011616 biotin Substances 0.000 claims description 7
- 235000020958 biotin Nutrition 0.000 claims description 5
- 230000008878 coupling Effects 0.000 claims description 5
- 238000010168 coupling process Methods 0.000 claims description 5
- 238000005859 coupling reaction Methods 0.000 claims description 5
- 239000003153 chemical reaction reagent Substances 0.000 claims description 4
- 239000000427 antigen Substances 0.000 claims description 3
- 108091007433 antigens Proteins 0.000 claims description 3
- 102000036639 antigens Human genes 0.000 claims description 3
- 239000000872 buffer Substances 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 238000000034 method Methods 0.000 abstract description 9
- 241000700605 Viruses Species 0.000 abstract description 4
- 230000007547 defect Effects 0.000 abstract description 3
- 238000012308 immunohistochemistry method Methods 0.000 abstract 1
- 229920000936 Agarose Polymers 0.000 description 39
- 108020004414 DNA Proteins 0.000 description 29
- 238000006243 chemical reaction Methods 0.000 description 14
- 206010008342 Cervix carcinoma Diseases 0.000 description 10
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 10
- 201000010881 cervical cancer Diseases 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 9
- 208000015181 infectious disease Diseases 0.000 description 8
- 239000007850 fluorescent dye Substances 0.000 description 6
- 239000013614 RNA sample Substances 0.000 description 5
- 238000001215 fluorescent labelling Methods 0.000 description 5
- 238000012408 PCR amplification Methods 0.000 description 4
- 238000011002 quantification Methods 0.000 description 4
- 206010059313 Anogenital warts Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 239000000969 carrier Substances 0.000 description 3
- 238000002372 labelling Methods 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 206010008263 Cervical dysplasia Diseases 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- 208000009608 Papillomavirus Infections Diseases 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 208000007951 cervical intraepithelial neoplasia Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000002073 fluorescence micrograph Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 2
- 208000007879 Atypical Squamous Cells of the Cervix Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 208000032420 Latent Infection Diseases 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 208000019065 cervical carcinoma Diseases 0.000 description 1
- 201000003565 cervix uteri carcinoma in situ Diseases 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000002380 cytological effect Effects 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000013500 data storage Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 239000000412 dendrimer Substances 0.000 description 1
- 229920000736 dendritic polymer Polymers 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037771 disease arising from reactivation of latent virus Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000013399 early diagnosis Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001917 fluorescence detection Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000002952 image-based readout Methods 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 238000003364 immunohistochemistry Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000009323 psychological health Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000004451 qualitative analysis Methods 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 210000005000 reproductive tract Anatomy 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 230000000405 serological effect Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 208000022159 squamous carcinoma in situ Diseases 0.000 description 1
- 210000004085 squamous epithelial cell Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 208000022625 uterine cervix carcinoma in situ Diseases 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/708—Specific hybridization probes for papilloma
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/04—Libraries containing only organic compounds
- C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810102320.6A CN108374039B (zh) | 2018-02-01 | 2018-02-01 | 一种人乳头瘤病毒的快速检测方法、液相芯片及试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810102320.6A CN108374039B (zh) | 2018-02-01 | 2018-02-01 | 一种人乳头瘤病毒的快速检测方法、液相芯片及试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108374039A CN108374039A (zh) | 2018-08-07 |
CN108374039B true CN108374039B (zh) | 2021-05-28 |
Family
ID=63017110
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810102320.6A Active CN108374039B (zh) | 2018-02-01 | 2018-02-01 | 一种人乳头瘤病毒的快速检测方法、液相芯片及试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108374039B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109112176A (zh) * | 2018-09-04 | 2019-01-01 | 武汉尚码生物科技有限公司 | 一种微球编码载体及其应用 |
CN111948185B (zh) * | 2020-08-21 | 2023-03-21 | 中国药科大学 | 基于二维扩增阵列模式的瞬时识别急性肾损伤发展进程的传感器、制备方法及用途和用法 |
CN112195281A (zh) * | 2020-11-12 | 2021-01-08 | 武汉凯德维斯生物技术有限公司 | 一种用于检测人乳头瘤病毒hpv56的探针及其试剂盒 |
CN112920267B (zh) * | 2021-03-09 | 2021-08-13 | 北京康乐卫士生物技术股份有限公司 | 一种抗人乳头瘤病毒31型的单克隆中和抗体及其应用 |
CO2021003728A1 (es) * | 2021-03-24 | 2021-09-30 | Univ El Bosque | Biosensor para la detección óptica de la infección por el virus del papiloma humano en fluidos biológicos |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20040083674A (ko) * | 2003-03-24 | 2004-10-06 | 바이오코아 주식회사 | 인유두종바이러스(hpv)유전자형 분석용 서스펜션어레이 마이크로스피어 비드 조성물 및 그 검사 방법 |
CN1814796A (zh) * | 2005-12-02 | 2006-08-09 | 浙江大学 | 一种用于26种人乳头瘤病毒的检测与分型的方法 |
CN1948503A (zh) * | 2005-10-10 | 2007-04-18 | 上海透景生命科技有限公司 | 一种人乳头瘤病毒检测分型方法及试剂盒 |
WO2008074182A1 (fr) * | 2006-12-18 | 2008-06-26 | Shanghai Tellgen Life Science Co., Ltd. | Procédé de détection et de typage du virus du papillome humain et kit de réactifs dudit procédé |
CN101760565A (zh) * | 2008-11-21 | 2010-06-30 | 叶军 | 一种悬浮芯片技术检测hpv方法 |
-
2018
- 2018-02-01 CN CN201810102320.6A patent/CN108374039B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20040083674A (ko) * | 2003-03-24 | 2004-10-06 | 바이오코아 주식회사 | 인유두종바이러스(hpv)유전자형 분석용 서스펜션어레이 마이크로스피어 비드 조성물 및 그 검사 방법 |
CN1948503A (zh) * | 2005-10-10 | 2007-04-18 | 上海透景生命科技有限公司 | 一种人乳头瘤病毒检测分型方法及试剂盒 |
CN1814796A (zh) * | 2005-12-02 | 2006-08-09 | 浙江大学 | 一种用于26种人乳头瘤病毒的检测与分型的方法 |
WO2008074182A1 (fr) * | 2006-12-18 | 2008-06-26 | Shanghai Tellgen Life Science Co., Ltd. | Procédé de détection et de typage du virus du papillome humain et kit de réactifs dudit procédé |
CN101760565A (zh) * | 2008-11-21 | 2010-06-30 | 叶军 | 一种悬浮芯片技术检测hpv方法 |
Also Published As
Publication number | Publication date |
---|---|
CN108374039A (zh) | 2018-08-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108374039B (zh) | 一种人乳头瘤病毒的快速检测方法、液相芯片及试剂盒 | |
CN100469895C (zh) | 用于乙肝病毒的荧光定量pcr检测试剂盒 | |
CN102985565B (zh) | 人乳头状瘤病毒的快速基因型鉴定分析及其装置 | |
CN111518948B (zh) | 逆转录多交叉置换扩增结合纳米生物传感检测SARS-CoV-2的方法 | |
CN102559868B (zh) | 一种单管定性并定量检测多个目标核酸序列的方法 | |
CN1814796A (zh) | 一种用于26种人乳头瘤病毒的检测与分型的方法 | |
EP2906726B1 (en) | Compositions and methods for detecting human papillomavirus nucleic acid | |
AU2010242168B2 (en) | A method for detection of human papillomavirus (HPV) type | |
CN110592279B (zh) | 检测hpv的组合物、试剂盒及方法 | |
US11293055B2 (en) | Nucleic acid detection kit and nucleic acid detection method using nanoparticles | |
CN109371148B (zh) | 鉴别三种猪呼吸道细菌的荧光pcr试剂盒及定量检测方法 | |
Kim et al. | Development and evaluation of a highly sensitive human papillomavirus genotyping DNA chip | |
CN113564278A (zh) | 一种液相芯片检测新型冠状病毒及其他呼吸道病毒的方法 | |
CN113186321A (zh) | 一种芽囊原虫绝对荧光定量pcr检测方法 | |
CN106048080B (zh) | 一种快速筛查hpv亚型的引物和方法 | |
KR101018407B1 (ko) | 인유두종 바이러스 진단용 프로브 및 그 유전자형 확인방법 | |
CN109613236B (zh) | 一种核酸杂交捕获免疫荧光检测方法、免疫荧光层析试条及试剂盒 | |
CN113667668B (zh) | 基于CRISPR/Cas系统的HBV检测 | |
KR101401940B1 (ko) | 고위험군 인유두종바이러스 유전자 분석용 키트 및 그 분석방법 | |
CN107058463B (zh) | 沙门菌h抗原鉴定用引物 | |
CN111593140B (zh) | 一种高危型人乳头瘤病毒的检测和分型试剂盒 | |
KR101152840B1 (ko) | Hpv 유전자형 진단용 프로브 및 그 분석방법 | |
CN113063943A (zh) | 用于检测高危型hpv病毒的试剂盒及检测方法 | |
CN102851395B (zh) | 一种检测传染性喉气管炎病毒的液相芯片方法 | |
US8741568B2 (en) | Detection of human papillomavirus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20191114 Address after: 430000 c281-6, floor 3, building B1, R & D building, zone B, C and D, Wuhan National biological industry base project, No. 666, Gaoxin Avenue, Donghu New Technology Development Zone, Wuhan City, Hubei Province Applicant after: WUHAN SHANGZHITANG BIOTECHNOLOGY CO.,LTD. Address before: 430000 C223-224, 3rd floor, B1 building, biological innovation park, 666 hi-tech Avenue, East Lake New Technology Development Zone, Wuhan, Hubei. Applicant before: WUHAN SUNMA BIOTECHNOLOGY CO.,LTD. |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220517 Address after: 100191 faculty dormitory, No. 6, Yiheyuan Road, Haidian District, Beijing Patentee after: Du Quan Address before: C281-6, 3rd floor, building B1, R & D building, zone B, C and D, Wuhan National biological industry base project, 666 Gaoxin Avenue, Donghu New Technology Development Zone, Wuhan City, Hubei Province, 430000 Patentee before: WUHAN SHANGZHITANG BIOTECHNOLOGY CO.,LTD. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240222 Address after: No. 2021 Beijing Road, Shanting Shancheng Street, Zaozhuang City, Shandong Province, 277299 Patentee after: Zaozhuang Kangze Biotechnology Co.,Ltd. Country or region after: China Address before: 100191 faculty dormitory, No. 6, Yiheyuan Road, Haidian District, Beijing Patentee before: Du Quan Country or region before: China |